Dr Reddys Announces Strategic Collaboration with Amgen in India
Dr Reddys Laboratories has entered into a strategic collaboration with Amgen to market and distribute three Amgen medicines in India […]
Say something
Tags: blood cancer, Business Partnership, cancer, Cardiovascular disease, Carfilzomib, Chemistry, Cholesterol, dexamethasone, Disease, Diseases, Dr. Reddy's Laboratories, Epoxides, European Commission, Health/Medical/Pharmaceuticals, Immunotherapy, India, Japan Asia Pacific, leukemia, Low-density lipoprotein, medicine, Morpholines, multiple myeloma, Organic chemistry, Orphan drugs, Penny Wan, philadelphia, Reddy, regulatory and commercial services, relapsed multiple myeloma, Statins, US Food and Drug Administration
-
-
Flipkart Health+ App Launched
06-04-2022
